AAV vectors: The Rubik's cube of human gene therapy

A Pupo, A Fernández, SH Low, A François… - Molecular Therapy, 2022 - cell.com
Defective genes account for∼ 80% of the total of more than 7,000 diseases known to date.
Gene therapy brings the promise of a one-time treatment option that will fix the errors in …

Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles

M Bonora, MR Wieckowski, DA Sinclair… - Nature Reviews …, 2019 - nature.com
A large body of evidence indicates that mitochondrial dysfunction has a major role in the
pathogenesis of multiple cardiovascular disorders. Over the past 2 decades, extraordinary …

Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells

G Liang, S Kan, Y Zhu, S Feng, W Feng… - International journal of …, 2018 - Taylor & Francis
Introduction Exosomes are closed-membrane nanovesicles that are secreted by a variety of
cells and exist in most body fluids. Recent studies have demonstrated the potential of …

In vivo genome editing restores dystrophin expression and cardiac function in dystrophic mice

M El Refaey, L Xu, Y Gao, BD Canan… - Circulation …, 2017 - Am Heart Assoc
Rationale: Duchenne muscular dystrophy is a severe inherited form of muscular dystrophy
caused by mutations in the reading frame of the dystrophin gene disrupting its protein …

The heterocellular heart: identities, interactions, and implications for cardiology

A Lother, P Kohl - Basic Research in Cardiology, 2023 - Springer
The heterocellular nature of the heart has been receiving increasing attention in recent
years. In addition to cardiomyocytes as the prototypical cell type of the heart, non-myocytes …

[HTML][HTML] The roles of lncRNA in myocardial infarction: molecular mechanisms, diagnosis biomarkers, and therapeutic perspectives

L Xie, Q Zhang, J Mao, J Zhang, L Li - Frontiers in cell and …, 2021 - frontiersin.org
In recent years, long non-coding RNAs (lncRNAs) have been demonstrated to be associated
with many physiological and pathological processes in cardiac. Recent studies have shown …

Mitochondrial dysfunction in cardiovascular disease: Current status of translational research/clinical and therapeutic implications

AS Manolis, AA Manolis, TA Manolis… - Medicinal Research …, 2021 - Wiley Online Library
Mitochondria provide energy to the cell during aerobic respiration by supplying~ 95% of the
adenosine triphosphate (ATP) molecules via oxidative phosphorylation. These organelles …

Calcium dysregulation in heart diseases: Targeting calcium channels to achieve a correct calcium homeostasis

G Morciano, A Rimessi, S Patergnani, VAM Vitto… - Pharmacological …, 2022 - Elsevier
Intracellular calcium signaling is a universal language source shared by the most part of
biological entities inside cells that, all together, give rise to physiological and functional …

[HTML][HTML] Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases

NK Younis, JA Ghoubaira, EP Bassil… - … , Biology and Medicine, 2021 - Elsevier
Cardiovascular disease (CVD) is the leading cause of death worldwide. A search for more
effective treatments of CVD is increasingly needed. Major advances in nanotechnology …

Gene therapy for ischaemic heart disease and heart failure

H Korpela, N Järveläinen, S Siimes… - Journal of Internal …, 2021 - Wiley Online Library
Gene therapy has been expected to become a novel treatment method since the structure of
DNA was discovered in 1953. The morbidity from cardiovascular diseases remains …